BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 22496568)

  • 1. Lysosomal dysfunction in a mouse model of Sandhoff disease leads to accumulation of ganglioside-bound amyloid-β peptide.
    Keilani S; Lun Y; Stevens AC; Williams HN; Sjoberg ER; Khanna R; Valenzano KJ; Checler F; Buxbaum JD; Yanagisawa K; Lockhart DJ; Wustman BA; Gandy S
    J Neurosci; 2012 Apr; 32(15):5223-36. PubMed ID: 22496568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.
    Huang JQ; Trasler JM; Igdoura S; Michaud J; Hanal N; Gravel RA
    Hum Mol Genet; 1997 Oct; 6(11):1879-85. PubMed ID: 9302266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the testis and epididymis in mouse models of human Tay Sachs and Sandhoff diseases and partial determination of accumulated gangliosides.
    Trasler J; Saberi F; Somani IH; Adamali HI; Huang JQ; Fortunato SR; Ritter G; Gu M; Aebersold R; Gravel RA; Hermo L
    Endocrinology; 1998 Jul; 139(7):3280-8. PubMed ID: 9645704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific induction of macrophage inflammatory protein 1-alpha in glial cells of Sandhoff disease model mice associated with accumulation of N-acetylhexosaminyl glycoconjugates.
    Tsuji D; Kuroki A; Ishibashi Y; Itakura T; Kuwahara J; Yamanaka S; Itoh K
    J Neurochem; 2005 Mar; 92(6):1497-507. PubMed ID: 15748167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of abnormal growth in astrocytes derived from a mouse model of GM2 gangliosidosis.
    Kawashima N; Tsuji D; Okuda T; Itoh K; Nakayama K
    J Neurochem; 2009 Nov; 111(4):1031-41. PubMed ID: 19765188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases.
    Phaneuf D; Wakamatsu N; Huang JQ; Borowski A; Peterson AC; Fortunato SR; Ritter G; Igdoura SA; Morales CR; Benoit G; Akerman BR; Leclerc D; Hanai N; Marth JD; Trasler JM; Gravel RA
    Hum Mol Genet; 1996 Jan; 5(1):1-14. PubMed ID: 8789434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inefficiency in GM2 ganglioside elimination by human lysosomal beta-hexosaminidase beta-subunit gene transfer to fibroblastic cell line derived from Sandhoff disease model mice.
    Itakura T; Kuroki A; Ishibashi Y; Tsuji D; Kawashita E; Higashine Y; Sakuraba H; Yamanaka S; Itoh K
    Biol Pharm Bull; 2006 Aug; 29(8):1564-9. PubMed ID: 16880605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous administration of scAAV9-Hexb normalizes lifespan and prevents pathology in Sandhoff disease mice.
    Niemir N; Rouvière L; Besse A; Vanier MT; Dmytrus J; Marais T; Astord S; Puech JP; Panasyuk G; Cooper JD; Barkats M; Caillaud C
    Hum Mol Genet; 2018 Mar; 27(6):954-968. PubMed ID: 29325092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of inducible models of Tay-Sachs and related disease.
    Sargeant TJ; Drage DJ; Wang S; Apostolakis AA; Cox TM; Cachón-González MB
    PLoS Genet; 2012 Sep; 8(9):e1002943. PubMed ID: 23028353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraneuronal Aβ detection in 5xFAD mice by a new Aβ-specific antibody.
    Youmans KL; Tai LM; Kanekiyo T; Stine WB; Michon SC; Nwabuisi-Heath E; Manelli AM; Fu Y; Riordan S; Eimer WA; Binder L; Bu G; Yu C; Hartley DM; LaDu MJ
    Mol Neurodegener; 2012 Mar; 7():8. PubMed ID: 22423893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism.
    Sango K; Yamanaka S; Hoffmann A; Okuda Y; Grinberg A; Westphal H; McDonald MP; Crawley JN; Sandhoff K; Suzuki K; Proia RL
    Nat Genet; 1995 Oct; 11(2):170-6. PubMed ID: 7550345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysosomal gene
    Whyte LS; Fourrier C; Hassiotis S; Lau AA; Trim PJ; Hein LK; Hattersley KJ; Bensalem J; Hopwood JJ; Hemsley KM; Sargeant TJ
    IBRO Neurosci Rep; 2022 Jun; 12():131-141. PubMed ID: 35146484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal accumulation of alpha- and beta-synucleins in the brain of a GM2 gangliosidosis mouse model.
    Suzuki K; Iseki E; Katsuse O; Yamaguchi A; Katsuyama K; Aoki I; Yamanaka S; Kosaka K
    Neuroreport; 2003 Mar; 14(4):551-4. PubMed ID: 12657883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganglioside-Mediated Assembly of Amyloid β-Protein: Roles in Alzheimer's Disease.
    Matsuzaki K; Kato K; Yanagisawa K
    Prog Mol Biol Transl Sci; 2018; 156():413-434. PubMed ID: 29747822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercholesterolemia accelerates intraneuronal accumulation of Aβ oligomers resulting in memory impairment in Alzheimer's disease model mice.
    Umeda T; Tomiyama T; Kitajima E; Idomoto T; Nomura S; Lambert MP; Klein WL; Mori H
    Life Sci; 2012 Dec; 91(23-24):1169-76. PubMed ID: 22273754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-Related Intraneuronal Aggregation of Amyloid-β in Endosomes, Mitochondria, Autophagosomes, and Lysosomes.
    Brewer GJ; Herrera RA; Philipp S; Sosna J; Reyes-Ruiz JM; Glabe CG
    J Alzheimers Dis; 2020; 73(1):229-246. PubMed ID: 31771065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macroautophagy is not directly involved in the metabolism of amyloid precursor protein.
    Boland B; Smith DA; Mooney D; Jung SS; Walsh DM; Platt FM
    J Biol Chem; 2010 Nov; 285(48):37415-26. PubMed ID: 20864542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis.
    Sango K; McDonald MP; Crawley JN; Mack ML; Tifft CJ; Skop E; Starr CM; Hoffmann A; Sandhoff K; Suzuki K; Proia RL
    Nat Genet; 1996 Nov; 14(3):348-52. PubMed ID: 8896570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal organization during neurodevelopment in a mouse model of Sandhoff disease.
    Ogawa Y; Sasanuma Y; Shitara S; Koshizuka A; Okada R; Sakuraba H; Oishi K
    Neurosci Res; 2020 Jun; 155():12-19. PubMed ID: 31340161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of intracerebroventricular replacement of modified human β-hexosaminidase B for GM2 gangliosidosis.
    Matsuoka K; Tamura T; Tsuji D; Dohzono Y; Kitakaze K; Ohno K; Saito S; Sakuraba H; Itoh K
    Mol Ther; 2011 Jun; 19(6):1017-24. PubMed ID: 21487393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.